Theiaa Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 M
About Theiaa Pharmacy
Theiaa Pharmacy Private Limited (TPPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 August 2021 (Three years and five months 22 days old ). Its registered office is in Pondicherry, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹5.00 M.
Appasamy Tamilselvan, Tamilselvan Kalaivani, Bhanupriya, and One other member serve as directors at the Company.
Company Details
-
Location
Pondicherry, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51397PY2021PTC008727
-
Company No.
008727
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Aug 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pondicherry
Industry
Who are the key members and board of directors at Theiaa Pharmacy?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Appasamy Tamilselvan
|
Director | 11-Aug-2021 | Current |
|
Tamilselvan Kalaivani
|
Director | 11-Aug-2021 | Current |
|
Bhanupriya
|
Director | 11-Aug-2021 | Current |
|
Prabhakaran
|
Director | 25-Nov-2021 | Current |
Financial Performance of Theiaa Pharmacy.
Enhance accessibility to Theiaa Pharmacy's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Theiaa Pharmacy?
Unlock access to Theiaa Pharmacy's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹5.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Feb 2024 | State Bank Of India | ₹5.00 M | Open |
How Many Employees Work at Theiaa Pharmacy?
Theiaa Pharmacy has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Theiaa Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Theiaa Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.